Last year, their project received support from MassChallenge, one of the largest startup accelerators in the world. In 2019, the dental startup raised US$1M in their first round of international investment from investors including GaneshaLab (US$250 thousand) and ChileGlobal Ventures de Fundación Chile (US$200 thousand), among others. This was the first investment by Ganesha Lab, a biotech accelerator in Santiago, Chile.
“The capital financing was quick, largely due to GaneshaLab’s constant strategic support,” says Budnik.
GaneshaLab has been helping scientific and technological Chilean businesses in the biotech, life sciences and biomedicine industries in their initial phase to raise private capital or help with global expansion since 2016.
In the first trimester of 2019, Purple Dental will start selling in United States.
“We will enter the market by selling directly to dentists through e-commerce, which will be complemented by digital channels that will leverage our network of advisers related to Harvard, Tufts, Forsyth Institute and ADA (American Dental Association),” Budnik commented.